HSP90B1 and glioma: Herein, we utilized multiplex immunofluorescence staining (MIS) and analyzed the RNA-seq data from The Cancer Genome Atlas (TCGA) and Chinese Glioma Genome Atlas (CGGA) to explore the clinicopathological, genetic, and immune features of gp96-expressing gliomas in a large cohort of patients.